A prospective, randomized trial to determine the early and late reactions after the use of iopamidol 340 (Niopam™) and iobitridol 350 (Xenetix®) in cardiac catheterization

Journal of Invasive Cardiology

Volumn 16, Issue 12, 2004, Pages 707-711

  Vijayalakshmi, Kunadian ^a   Williams, David ^a   Wright, Robert A ^a   Hall, James A ^a   Harcombe, Alun A ^a   Linker, Nicholas J ^a   Stewart, Michael J ^a   Davies, Adrian ^a   De Belder, Mark A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; IOBITRIDOL; IOPAMIDOL; DRUG DERIVATIVE; IOHEXOL;

ARTICLE; CARDIOVERSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECG ABNORMALITY; ELECTROCARDIOGRAPHY; HEART CATHETERIZATION; HEART DISEASE; HEART RATE; HEART VENTRICLE FIBRILLATION; HEAT SENSATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; PRURITUS; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SENSORY DYSFUNCTION; SKIN MANIFESTATION; ADULT; AGED; DOUBLE BLIND PROCEDURE; FEMALE; MALE; METHODOLOGY; MIDDLE AGED; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HUMANS; IOHEXOL; IOPAMIDOL; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 16644370477     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Katayama H, Yamaguchi K, Kozuka T, et al. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 1990;175:621-628.
2. Palmer F. The RACR survey of intravenous contrast media reactions. Final report. Australas Radiol 1988;31:621-628.
3. Donadieu A, Idee J, Doucet D, et al. Toxicological profile of iobitridol 350, a new nonionic lowosmolality contrast medium. Acta Radiologica 1996;37:17-24.
4. Drouillard J, Froment J, Frija G, et al. Efficacy and safety of iobitridol 350 versus iohexol for contrast-enhanced CT of the head. Acta Radiologica 1996;37:56-61.
5. Meiss L, Bakker A, Falke T, Van Waes P. Clinical safety and efficacy of iobitridol 350 in urography. Acta Radiologica 1996;(Suppl 400):71.
6. Bouard J, Lyonnet D, Illes J, et al. Experience with iobitridol 350 250-300 in digital subtraction angiography. Acta Radiologica 1996;37:85-88.
7. Lefevre T, Funck F, Aliot E, Ethevenot B. Safety and efficacy of the new iodinated nonionic low-osmolality contrast medium iobitridol 350 (Xenetix® ) in coronary and ventricular angiography. Acta Radiologica 1996;37:75-80.
8. Petersein J, Peters C, Wolf M, Hamm B. Results of safety and efficacy of iobitridol 350 in more than 61,000 patients. Eur Radiol 2003;13:2006-2011.
9. Sutton A, Finn P, Grech E, et al. Early and late reactions after the use of iopamidol 340, ioxaglate 320, and iodixanol 320 in cardiac catheterization. Am Heart J 2001;141:677-683.
10. Sutton A, Finn P, Campbell P, et al. Early and late reactions following the use of iopamidol 340, iomeprol 350 and iodixanol 320 in cardiac catheterization. J Invas Cardiol 2003;15:133-138.